| Literature DB >> 33903777 |
Khalissa Benbouguerra1,2, Nadjib Chafai1, Salah Chafaa1, Youcef IslamTOUAHRIA1, Hamida Tlidjane1.
Abstract
A new α-Hydrazinophosphonic acid (HDZPA) has been synthesized and its molecular structure was determined using spectroscopic methods. The Density Functional Theory (DFT) at the B3LYP/6-31G (d,p) level was utilized to determine the electronic properties, vibrational modes and active sites of the examined molecule. In this context, some quantum chemical parameters have been calculated in order to discuss the reactivity of the studied molecule. Also, the inhibition activity of the investigated α-Hydrazinophosphonic acid for SARS-CoV-2 main protease (Mpro) and RNA dependent RNA polymerase (RdRp) has been predicted using in silico docking.Entities:
Keywords: Characterization; DFT; SARS-CoV-2 main protease; Synthesis; in silico docking; α-Hydrazinophosphonic Acid
Year: 2021 PMID: 33903777 PMCID: PMC8059216 DOI: 10.1016/j.molstruc.2021.130480
Source DB: PubMed Journal: J Mol Struct ISSN: 0022-2860 Impact factor: 3.196
Fig. 1Synthetic rout of the studied α-Hydrazinophosphonic acid ligand (HDZPA).
Fig. 2Crystal structures of Mpro and RdRp.
Fig. 3Experimental and calculated UV–Vis spectra of HDZPA.
Fig. 6Optimized structure, MEP maps, HOMO and LUMO frontier orbitals of HDZPA.
Experimental and calculated values of wavenumber for the selected vibrations of HDZPA.
| Assignment (% PED) | Vibrational frequency (cm−1) | ||
|---|---|---|---|
| Experimental | Theoretical | ||
| Unscaled | Scaled | ||
| ν O – H (98) | 3621 (ν O – H) | 3788 | 3641 |
| ν N – H (100) | 3315 (ν N – H) | 3425 | 3293 |
| ν C – HAr (96) | 3250 (C – HAr) | 3353 | 3223 |
| νs C – HAlph (97), β H—C-H (96) | 2998 (νs C – HAlph) | 3142 | 3020 |
| νs C – HAlph (94), β HCN (24) | 2980 (νs C – HAlph) | 3117 | 2996 |
| νas C – HAlph (84), β HCC (29), ρ CCHC (45), ρout CCCH (57) | 2884 (νas C – HAlph) | 3108 | 2988 |
| ν | 1611 (ν P – OH) | 1674 | 1609 |
| γ C—H (25), β HCN (20), ρ OPHC (18) | 1411 (γ C—H) | 1459 | 1402 |
| α C—H (34), β HCN (16), β HCH (12) | 1378 (α C—H) | 1393 | 1342 |
| ω C—H (39), β HCH (10), ρ HCHP (13) | 1351 (ω C—H) | 1382 | 1328 |
| ν N – CAr (52), α C—H (31), β CCH (13), β CCN (18), β HCH (22), ρout CCCH (11) | 1269 (ν N – CAr) | 1283 | 1234 |
| ν | 1202 (ν | 1242 | 1194 |
| ν N – N (22), γ C—H (14), γ PCH (31), ω C—H (24) | 1168 (ν N – N) | 1186 | 1140 |
| ω C—H (24), β HCP (32), β HCH (25), ρ HCNC (16), ρ OPCN (19) | 1084 (ω C—H) | 1125 | 1081 |
| γ C—H (35), δ C—H (10), β C—N (12), ρ P-O (43) | 1041 (ρ P-O) | 1066 | 1024 |
| ν N – CAlph (34), β HCC (23), β CCC (28), ρ CCHC (10) | 1020 (ν N – CAlph) | 1052 | 1011 |
| δ C—H (41), γ C-P (27), β HCC (13), β OPC (12), β HOP (11), ρ OPCN (10) | 748 (γ C-P) | 772 | 742 |
| δ C—H (17), ν C-P (24), β HOP (26), β HCH (32), ρ OPC (14) | 684 (ν C-P) | 714 | 686 |
ν: stretching, γ: rocking, α: scissoring, δ: twisting, ω: wagging, β: in plane bending, ρ: torsion, ρout : out plane bending, s: symmetric, as: asymmetric.
Fig. 5Correlation diagram between the calculated and experimental wavenumbers of HDZPA.
Fig. 4Experimental and calculated IR spectra of HDZPA.
Experimental and calculated NMR chemical shifts (δ in ppm) for HDZPA.
| 1H NMR | 13C NMR | 31P NMR | |||
|---|---|---|---|---|---|
| Experimental | Calculated | Experimental | Calculated | Experimental | Calculated |
| 2.48 | 2.10 | 23.84 | 12.55 | 8.42 | 8.94 |
| 3.12 | 3.90 | 67.95 | 52.03 | 9.13 | 8.95 |
| 5.08 | 5.10 | 68.2 | 57.34 | ||
| 7.05 | 8.50 | 114.14 | 113.76 | ||
| 7.08 | 8.58 | 120.36 | 115.22 | ||
| 7.12 | 8.58 | 122.15 | 115.31 | ||
| 7.15 | 8.61 | 129.35 | 115.79 | ||
| 8.92 | 8.80 | 129.67 | 125.11 | ||
| 137.37 | 130.98 | ||||
Calculated quantum chemical parameters of HDZPA using DFT/B3LYP 6–31 G (d,p) method.
| Quantum chemical parameters | HDZPA |
|---|---|
| ETot (eV) | – 43437.641 |
| EHOMO (eV) | – 7.9536200 |
| ELUMO (eV) | – 0.1333359 |
| ΔEGAP (eV) | 7.8202841 |
| μ (Debye) | 4.87960000 |
| η (eV) | 3.91014205 |
| Σ | 0.25574518 |
| χ (eV) | 4.04347795 |
| ω | 2.09068030 |
Calculated Mullikan atomic charges of HDZPA.
| Atom | Mulliken Charge |
|---|---|
| C1 | - 0.1602500 |
| C2 | - 0.2060730 |
| C3 | 0.2726000 |
| C4 | - 0.1716900 |
| C5 | - 0.1688970 |
| C6 | - 0.0401750 |
| H7 | 0.1619580 |
| H8 | 0.1675950 |
| H9 | 0.1784940 |
| H10 | 0.1600150 |
| C11 | - 0.3415360 |
| H12 | 0.1276730 |
| H13 | 0.1287390 |
| H14 | 0.1330520 |
| N15 | - 0.5272320 |
| H16 | 0.3072080 |
| N17 | - 0.4714520 |
| C18 | - 0.2857870 |
| H19 | 0.1834720 |
| H20 | 0.1942020 |
| C21 | - 0.2843220 |
| H22 | 0.1780410 |
| H23 | 0.1889790 |
| P24 | 1.5113980 |
| O25 | - 0.7163540 |
| H26 | 0.4000000 |
| O27 | - 0.7174640 |
| H28 | 0.4056340 |
| O29 | - 0.7042910 |
| O30 | - 0.6919460 |
| H31 | 0.4038440 |
| O32 | - 0.7710550 |
| O33 | - 0.7617180 |
| H34 | 0.4031740 |
| P35 | 1.5141630 |
Fig. 7Best docked model visualization of HDZPA ligand with SARS-CoV-2 main protease (a) and RNA dependent RNA polymerase (b).
Fig. 83D and 2D Binding-interaction diagrams of HDZPA ligand with SARS-CoV-2 main protease (a) and RNA dependent RNA polymerase (b).
Molecular docking results of HDZPA and some drugs with Mpro and RdRp.
| Compounds | Mpro Binding energy in Kcal/mol | RdRp Binding energy in Kcal/mol |
|---|---|---|
| This work (HDZPA) | −6.00 | −7.70 |
| Chloroquine | −4.9 | −5.4 |
| Hydroxychloroquine | −5.5 | −5.6 |
| Remdesivir [ | −4.96 | −7.60 |